EL - The Estée Lauder Comp... Stock Analysis | Stock Taper
Logo
The Estée Lauder Companies Inc.

EL

The Estée Lauder Companies Inc. NYSE
$88.95 -2.11% (-1.92)

Market Cap $32.17 B
52w High $121.64
52w Low $64.83
Dividend Yield 1.49%
Frequency Quarterly
P/E -127.07
Volume 2.70M
Outstanding Shares 361.67M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2026 $3.71B $2.28B $89M 2.4% $0.25 $557M
Q2-2026 $4.24B $2.66B $162M 3.82% $0.45 $782M
Q1-2026 $3.48B $2.38B $47M 1.35% $0.13 $395M
Q4-2025 $3.41B $2.44B $-546M -16.03% $-1.51 $-123M
Q3-2025 $3.55B $2.35B $159M 4.48% $0.44 $532M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2026 $3.13B $19.66B $15.67B $3.99B
Q2-2026 $3.08B $19.63B $15.6B $4.03B
Q1-2026 $2.22B $19.33B $15.44B $3.89B
Q4-2025 $2.92B $19.89B $16.03B $3.87B
Q3-2025 $2.63B $19.89B $15.54B $4.34B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2026 $89M $412M $-96M $-263M $44M $310M
Q2-2026 $162M $1.13B $-92M $-180M $863M $1.02B
Q1-2026 $47M $-340M $-116M $-239M $-702M $-436M
Q4-2025 $-546M $601M $-215M $-128M $290M $394M
Q3-2025 $159M $284M $-135M $-117M $45M $162M

Revenue by Products

Product Q4-2025Q1-2026Q2-2026Q3-2026
Fragrance
Fragrance
$560.00M $720.00M $810.00M $630.00M
Hair Care
Hair Care
$140.00M $130.00M $170.00M $130.00M
Makeup
Makeup
$980.00M $1.03Bn $1.16Bn $1.07Bn
Skin Care
Skin Care
$1.71Bn $1.57Bn $2.05Bn $1.86Bn

Revenue by Geography

Region Q4-2025Q1-2026Q2-2026Q3-2026
Asia Pacific
Asia Pacific
$1.17Bn $870.00M $900.00M $1.00Bn
UNITED STATES
UNITED STATES
$950.00M $1.17Bn $1.22Bn $1.08Bn
EMEA
EMEA
$1.29Bn $0 $0 $0

Q3 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at The Estée Lauder Companies Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Estée Lauder still benefits from powerful global brands, high underlying product margins, and a broad multi‑brand, multi‑channel footprint in prestige beauty. Its culture of scientific and product innovation, now reinforced with AI and digital capabilities, provides tools to adapt to changing consumer needs. The asset base and retained earnings remain meaningful, and management has shown a willingness to adjust dividends and buybacks to protect liquidity when needed.

! Risks

The main risks center on sustained revenue decline, margin compression, and rising leverage. The company has moved from strong profits to material losses, while its cost base remains heavy and less flexible than conditions demand. Liquidity has weakened, debt reliance has increased, and equity has shrunk, reducing financial resilience. Competitive and execution risks are also elevated: if innovation, channel strategy, and geographic focus are misaligned with market trends, the company may continue to lose ground despite its strong starting position.

Outlook

The near‑term outlook is cautious. The business is in a clear turnaround phase, working to stabilize sales, right‑size costs, and rebuild earnings and cash flow. Success is not assured, but the ingredients for recovery—strong brands, high gross margins, and a more ambitious innovation engine—are present. Over time, outcomes will depend on how effectively management can convert its “Beauty Reimagined” and digital strategies into tangible improvements in growth, profitability, and balance‑sheet strength, while navigating a highly competitive and fast‑changing beauty landscape.